• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The role of weight control in the management of type 2 diabetes mellitus: Bariatric surgery.体重控制在 2 型糖尿病管理中的作用:减重手术。
Diabetes Res Clin Pract. 2023 May;199:110667. doi: 10.1016/j.diabres.2023.110667. Epub 2023 Apr 8.
2
Comparison of Benefits and Risks of Metabolic Surgery for Long-Term (5 Years) Weight Loss and Diabetes Remission in Overweight/Obese Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized Trials.代谢手术对超重/肥胖2型糖尿病患者长期(5年)体重减轻和糖尿病缓解的益处与风险比较:一项随机试验的系统评价和网状Meta分析
Diabetes Metab Res Rev. 2025 Mar;41(3):e70033. doi: 10.1002/dmrr.70033.
3
Position statement and guidelines about Endoscopic Sleeve Gastroplasty (ESG) also known as "Endo-sleeve".关于内镜下袖状胃成形术(ESG,也称为“内镜袖套术”)的立场声明和指南。
J Visc Surg. 2025 Feb;162(1):71-78. doi: 10.1016/j.jviscsurg.2024.12.003. Epub 2025 Jan 9.
4
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
5
Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease.十二指肠黏膜消融:代谢功能障碍相关脂肪性肝病的一种新兴治疗理念。
World J Gastroenterol. 2025 Jul 28;31(28):109468. doi: 10.3748/wjg.v31.i28.109468.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Bariatric surgery for pediatric extreme obesity: now or later?小儿极度肥胖的减肥手术:现在做还是以后做?
Int J Obes (Lond). 2007 Jan;31(1):1-14. doi: 10.1038/sj.ijo.0803525.
8
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
9
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.肥胖症减肥干预措施以提高子宫内膜癌女性的生存率。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3.
10
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.

引用本文的文献

1
Global trends and hotspots in diabetes and obesity research: A bibliometric analysis.糖尿病与肥胖症研究的全球趋势和热点:一项文献计量分析。
J Family Med Prim Care. 2025 Apr;14(4):1155-1160. doi: 10.4103/jfmpc.jfmpc_1472_24. Epub 2025 Apr 25.
2
Effectiveness of Calorie Restriction for Weight Loss in Type 2 Diabetes Mellitus: A Systematic Review.热量限制对2型糖尿病患者体重减轻的有效性:一项系统评价。
Cureus. 2025 Feb 1;17(2):e78348. doi: 10.7759/cureus.78348. eCollection 2025 Feb.
3
Efficacy and safety of semaglutide combined with metformin in treating T2DM with overweight or obesity: a systematic review and meta-analysis.司美格鲁肽联合二甲双胍治疗超重或肥胖2型糖尿病的疗效和安全性:一项系统评价和荟萃分析
Am J Transl Res. 2024 Aug 15;16(8):3545-3556. doi: 10.62347/RYLN5360. eCollection 2024.
4
Beyond pounds: What else could be lost?除了体重:还有什么可能会流失?
J Diabetes Complications. 2023 Dec;37(12):108649. doi: 10.1016/j.jdiacomp.2023.108649. Epub 2023 Nov 19.
5
Regulation of Human Sortilin Alternative Splicing by Glucagon-like Peptide-1 (GLP1) in Adipocytes.人源分选连接蛋白可变剪接受胰高血糖素样肽-1(GLP1)调控在脂肪细胞中的作用。
Int J Mol Sci. 2023 Sep 20;24(18):14324. doi: 10.3390/ijms241814324.

本文引用的文献

1
Scores for Predicting Diabetes Remission in Bariatric Surgery: a Systematic Review and Meta-analysis.预测减重手术中糖尿病缓解的评分:一项系统评价和荟萃分析
Obes Surg. 2023 Feb;33(2):600-610. doi: 10.1007/s11695-022-06382-5. Epub 2022 Dec 1.
2
The postprandial secretion of peptide YY and in obesity is differentially increased after gastric bypass versus sleeve gastrectomy.胃旁路术与袖状胃切除术对肥胖患者餐后肽 YY 和 的分泌影响不同。
Clin Endocrinol (Oxf). 2023 Sep;99(3):272-284. doi: 10.1111/cen.14846. Epub 2022 Nov 28.
3
Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.腹腔镜袖状胃切除术与 Roux-en-Y 胃旁路术对肥胖成年患者体重减轻、合并症和反流的 10 年影响:SLEEVEPASS 随机临床试验。
JAMA Surg. 2022 Aug 1;157(8):656-666. doi: 10.1001/jamasurg.2022.2229.
4
The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass.人类肠道微生物群有助于 Roux-en-Y 胃旁路手术后 5 年 2 型糖尿病的缓解。
Gut Microbes. 2022 Jan-Dec;14(1):2050635. doi: 10.1080/19490976.2022.2050635.
5
Laparoscopic sleeve gastrectomy for morbid obesity improves gut microbiota balance, increases colonic mucosal-associated invariant T cells and decreases circulating regulatory T cells.腹腔镜袖状胃切除术治疗病态肥胖症可改善肠道微生物群落平衡,增加结肠黏膜相关不变 T 细胞,减少循环调节性 T 细胞。
Surg Endosc. 2022 Oct;36(10):7312-7324. doi: 10.1007/s00464-022-09122-z. Epub 2022 Feb 19.
6
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study).2 型糖尿病患者行十二指肠黏膜表面重建(DMR)术后 2 年持久的代谢改善(REVITA-1 研究)。
Diabetes Res Clin Pract. 2022 Feb;184:109194. doi: 10.1016/j.diabres.2022.109194. Epub 2022 Jan 13.
7
Acute Effects of Sleeve Gastrectomy on Glucose Variability, Glucose Metabolism, and Ghrelin Response.袖状胃切除术对血糖变异性、糖代谢和胃饥饿素反应的急性影响。
Obes Surg. 2021 Sep;31(9):4005-4014. doi: 10.1007/s11695-021-05534-3. Epub 2021 Jul 8.
8
The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis.肥胖症手术对伴有非酒精性脂肪性肝病且存在高纤维化风险的接受胰岛素治疗的 2 型糖尿病成人患者的代谢和肝脏相关结局。
Surg Obes Relat Dis. 2021 Apr;17(4):792-798. doi: 10.1016/j.soard.2020.11.015. Epub 2020 Nov 20.
9
Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery.肝脂肪变性的存在与胃旁路手术后糖尿病缓解率增加相关。
Diabetes Care. 2021 Feb;44(2):321-325. doi: 10.2337/dc20-0150. Epub 2020 Dec 15.
10
Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.腹腔镜袖状胃切除术与 Roux-en-Y 胃旁路术治疗病态肥胖患者 7 年的减肥效果和生活质量比较:SLEEVEPASS 随机临床试验。
JAMA Surg. 2021 Feb 1;156(2):137-146. doi: 10.1001/jamasurg.2020.5666.

体重控制在 2 型糖尿病管理中的作用:减重手术。

The role of weight control in the management of type 2 diabetes mellitus: Bariatric surgery.

机构信息

Division of Minimally Invasive and Gastrointestinal Surgery, The Medical College of Wisconsin, United States.

Division of Minimally Invasive and Gastrointestinal Surgery, The Medical College of Wisconsin, United States.

出版信息

Diabetes Res Clin Pract. 2023 May;199:110667. doi: 10.1016/j.diabres.2023.110667. Epub 2023 Apr 8.

DOI:10.1016/j.diabres.2023.110667
PMID:37037264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10192054/
Abstract

Diabetes mellitus is one of the major epidemics in the United States. It is heavily associated with obesity and multiple metabolic derangements that lead to long term morbidity, mortality as well as financial burden. Although medical therapy has been the mainstay in the management of diabetes mellitus, there remains a large portion of this patient population which struggles to obtain adequate glycemic control and long-term weight control with medical management alone. Bariatric surgery is a powerful tool in combating diabetes mellitus and affects glucose homeostasis through a variety of pathways. While it does provide a durable pathway for weight loss, improvement in glucose homeostasis is not only affected by the weight loss seen after bariatric surgery. Changes in gut hormone secretion, insulin regulation, and gut microbial composition also affect how these operations improve glucose homeostasis. Through improvement in the management of diabetes mellitus, comorbidities including cardiovascular disease, in turn demonstrate improvement. In this article, we will discuss the role of bariatric (metabolic) surgery as it relates to long term weight loss and the impact that weight loss has on improvement in diabetes mellitus.

摘要

糖尿病在美国是一种主要的流行病。它与肥胖和多种代谢紊乱密切相关,导致长期发病率、死亡率以及经济负担。尽管医学治疗一直是糖尿病管理的主要方法,但仍有很大一部分患者群体仅通过医学管理难以获得足够的血糖控制和长期体重控制。减重手术是治疗糖尿病的有力工具,通过多种途径影响葡萄糖稳态。虽然它确实为减肥提供了持久的途径,但葡萄糖稳态的改善不仅受到减重手术后体重减轻的影响。肠道激素分泌、胰岛素调节和肠道微生物组成的变化也会影响这些手术如何改善葡萄糖稳态。通过改善糖尿病的管理,包括心血管疾病在内的合并症也随之得到改善。在本文中,我们将讨论减重(代谢)手术在长期减肥方面的作用,以及减肥对改善糖尿病的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/10192054/2aca762c9af9/nihms-1891820-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/10192054/59a0ae93faac/nihms-1891820-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/10192054/2aca762c9af9/nihms-1891820-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/10192054/59a0ae93faac/nihms-1891820-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d41/10192054/2aca762c9af9/nihms-1891820-f0002.jpg